Ashmari is the formation of stone in Mootravaha srotas, resulting in severe pain as given by the enemy. It is an effect of the complex, physicochemical process that involves a sequence of events in the formation of any urinary stones, including urinary saturation, supersaturation, nucleation and growth of crystals, aggregation and retention of crystals, and finally, stone formation. It affects about 12% of the world's population at some stage in their lifetime in all age groups, sexes, and races but occurs more frequently in men than women aged 20 to 49 years. In India, about 12% of the total population is expected to have urinary stones in their life, out of which 50% may end up with loss of kidney function. Contemporary treatment such as Lithotripsy (ESWL), Percutaneous Nephrolithotomy (PCNL), Retrograde Intra-renal surgery (RIRS), and Laparoscopic Ureter lithotomy adopted in the condition of Urolithiasis is quite costly with high incidence of recurrence. For the present study, Nagaradi Kwatha and Chandraprabha Vati were administered for 14 days. Each patient was observed on the 0-day, 7th, and 15th day of drug intervention with said parameters. The study showed significant clinical improvement in reducing the shoola, mootradosha, Kruchramutrata, and Sarakta mootrata and showed good response in disintegration and the expulsion of Ashmari.
Read full abstract